Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News General Electric Company GE

GE was formed through the combination of two companies in 1892, including one with historical ties to American inventor Thomas Edison. Today, GE is a global leader in air travel, precision health, and in the energy transition. The company is known for its differentiated technology and its massive industrial installed base of equipment sprawled throughout the world. That installed base most notably includes aerospace engines, gas and steam turbines, onshore and offshore wind turbines, as well...

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NYSE:GE)

Fundamentals Snapshot (NYSE:GE)

Bullboard Posts (NYSE:GE)

Architectural Lighting Market Analysis and Forecast 2022-27

The IMARC Group provides extensive analysis of the architectural lighting industry covering the market trends, investment...
edwardebreen15 - July 27, 2022

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

SophiaBrown - July 13, 2022

FSD will proceed with Phase2 of FSD-201 soon after clearance

<< View Post To Watch Video >>
SophiaBrown - June 3, 2022

FSD Pharma Files Investigational New Drug Application (“IND”

   
SophiaBrown - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

SophiaBrown - May 10, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
SophiaBrown - April 30, 2022